InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,813.11
(
-0.12%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

$heff

Send PM Follow Ignore
Followers 3422
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

$heff

Re: $heff post# 83789

Tuesday, 10/28/2014 3:57:13 AM

Tuesday, October 28, 2014 3:57:13 AM

Post# of 97237
$CERS..The INTERCEPT plasma system license application is under FDA review, with an approval decision expected in 2015. The INTERCEPT system has been approved for use in Europe for eight years and is used in over 100 blood centers outside the US.

1http://jid.oxfordjournals.org/content/179/Supplement_1/S18.long
2http://www.who.int/mediacentre/news/ebola/26-september-2014/en/
3 (Luke, T. C., A. Casadevall, et al. (2010). "Hark back: passive immunotherapy for influenza and other serious infections." Crit Care Med 38(4 Suppl): e66-73)

Sheff's Station...All Aboard...Sign Up Here!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up